Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...

While the risk of contracting and dying from the H5N1 avian flu remains low for humans, researchers continue to hunt for ...

This virus was named Influenza B and the inactivated influenza ... After two doses, there was an eight- to ninefold increase in antibody titer, measured by the hemagglutination inhibition assay.

Jan. 30, 2025 — The antibody targets a stable part of the ... Jan. 2, 2025 — Highly pathogenic H5N1 avian influenza A virus (HPAI H5N1) remains a low risk to the general public, and public ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

While current influenza vaccines primarily target the variable hemagglutinin protein, the slower-evolving neuraminidase presents a promising target for the development of new vaccines providing ...

These new insights pave the way towards intranasal antibody delivery to provide protection against influenza and other airborne viruses. Clarissa Koch, PhD, Chief Research Officer of Leyden Labs ...

While the risk of contracting and dying from the H5N1 avian flu remains low for humans, researchers continue to hunt for ...

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...